Navidea Biopharmaceutics Stock
Your prediction
Pros and Cons of Navidea Biopharmaceutics in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Navidea Biopharmaceutics vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Navidea Biopharmaceutics | - | - | - | - | - | - | - |
Organovo Holdings Inc. | 2.430% | -2.061% | 1.804% | -43.136% | -11.988% | -86.339% | -91.147% |
Intellia Therapeutics Inc | -3.020% | -13.968% | -9.171% | -48.457% | -31.917% | -66.907% | 57.680% |
VBI Vaccines Inc. | 1.670% | -6.961% | 4.580% | -79.084% | 3.396% | -99.359% | -98.950% |
News
Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
Navidea Biopharmaceuticals, Inc. (OTC: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that it